Daxor corporation ceo and president michael feldschuh provides corporate update in letter to shareholders

Oak ridge, tn, aug. 28, 2023 (globe newswire) -- daxor corporation (nasdaq: dxr), the global leader in blood volume measurement technology, today issued a corporate update in a letter to shareholders filed in its six-month shareholder report on form n-csr on august 28, 2023 from ceo and president, michael feldschuh.
DXR Ratings Summary
DXR Quant Ranking